NCT05964101View on ClinicalTrials.gov

Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

August 1, 2025

Study Completion Date

May 31, 2026

Conditions
NeoplasmsCarcinoma, SquamousAntineoplastic Agents
Interventions
DRUG

Nivolumab Injection [Opdivo]

Neoadjuvant treatment stage: Nivolumab +Carboplatin AUC+ paclitaxel

Trial Locations (1)

510120

RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

The First Affiliated Hospital of Guangzhou Medical University

OTHER